WORLD ORPHAN DRUG CONGRESS - EUROPE 2026

Description

The World Orphan Drug Congress Europe is the largest and most established European event dedicated to rare diseases and orphan drugs. It serves as a global gathering for the entire ecosystem, including pharmaceutical and biotech companies, government regulators, patient advocacy groups, and payers. The congress focuses on the most pressing challenges in the industry, such as clinical development, market access, commercialization, and gene therapy. By fostering collaboration between stakeholders, the event aims to accelerate the delivery of life-saving treatments to patients with rare diseases worldwide.

Exhibits

Showcases from biotech firms, CROs, CDMOs, and technology providers offering solutions for rare disease research, manufacturing, and patient data management.

Activities

Strategic keynotes, panel discussions, roundtable sessions, speed networking, and the prestigious Orphan Drug Awards ceremony.

Speakers

Executives from top pharma (Roche, Pfizer, Novartis), regulators from EMA and FDA, leaders of global patient organizations, and health economists.

Demos

Live presentations of digital health platforms, innovative clinical trial recruitment tools, and advanced therapeutic delivery systems.

Accessibility

The event is traditionally held at the Fira de Barcelona (Gran Via). From Barcelona-El Prat Airport (BCN), take the L9 Sud metro line directly to Fira station, or use the Aerobús to Plaça d'Espanya.

Exhibitor Count

150

Expected Attendance

1500

You must be logged in to comment on this event.